Delivery Order SPE2DB22D6029-SPE2DB25FLVQX
- Not listed
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CEFIXIME 200 MG/5 ML SUSP 75ML. The contract has a ceiling value of $1,305.48 and a period of performance through July 3, 2025. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with the DLA Troop...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,026,246 units of the antibiotic drug Cefixime 400 mg capsules. The contract has a firm fixed price of $10,740.68 and a completion date of October 7, 2024. The award is not associated with any set-aside program. AmerisourceBergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999...
- This federal contract award, valued at $15,150.16, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Cefixime 200 mg/5 ml suspension in 75 ml bottles. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has established itself as a key vendor for federal healthcare programs, particularly within military and...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,870.33, is for the delivery of CEFIXIME 400 MG CAPSULE 50S, a medication used to treat various bacterial infections. The contract has no set-aside designation, indicating it was an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract is for the supply of Cefixime 200 mg/5 ml oral suspension in 75 ml bottles, with a ceiling value of $1,051.60 and a performance period through August 30, 2024. The contract is a firm-fixed-price type with no set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts...
- This federal contract award from the Defense Logistics Agency (DLA) was made to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The $3,159.96 Firm Fixed Price Delivery Order provides Cefixime 400 mg capsules to the DLA. This award is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred forty-four thousand dollars to Amerisourcebergen Drug Corporation for the supply of four hundred fifty-six thousand, one hundred thirty-four units of four hundred milligram Cefixime capsules. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery required between June twenty-seventh and twenty-eighth of twenty twenty-three. As a leading provider of...
- This is a delivery order federal contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), an agency of the U.S. Department of Defense. The contract is for the delivery of CEFIXIME 400 MG CAPSULE 50S, a pharmaceutical product, with a ceiling value of $3,926.22 and a completion date of July 11, 2025. The contract is a Firm Fixed Price Delivery Order, without a set-aside designation, indicating open...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $14,473.21 firm-fixed-price delivery order is for the supply of Cefixime 400 mg capsules, a common antibiotic medication. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00. This single-award IDC serves as the primary...
- The Defense Logistics Agency awarded a $1,228.56 delivery order to AmerisourceBergen Drug Corp for Cefazolin 2G/50ML-Dextrose, an antibiotic pharmaceutical product, with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's larger federal contracting portfolio with the agency. This delivery order derives...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB25FLVQXDelivery Order
The Defense Logistics Agency awarded a $4,436.48 delivery order to AmerisourceBergen Drug Corp for Cefixime 200 mg/5 ml suspension in a 75 ml quantity. This non-set-aside, firm fixed-price delivery order is scheduled for completion by July 31, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, is fulfilling this requirement as a child delivery order under a larger contract vehicle. This delivery order falls under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.4k | 7/30/25 |